Platelet Aggregation, β-Thromboglobulin and Platelet Factor 4 in Diabetes Mellitus and in Patients with Vasculopathy
- 1 December 1984
- journal article
- research article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 52 (03), 236-239
- https://doi.org/10.1055/s-0038-1661186
Abstract
We have studied 155 subjects, 48 normals, 36 diabetics without complications, 44 with complications and 27 patients with macroangiopathy. β-Thromboglobulin (β-TG) and platelet factor 4 (PF4) are elevated in the patients groups. There is no correlation between the plasma levels of β-TG and the stages of either retinopathy or macroangiopathy or nephropathy. The difference is more marked between normals and diabetics with neuropathy (p = 0.026). The aggregation response to ADP and platelet activating factor (PAF) is enhanced at lower stimulator concentration. Using the β-TG, PF4 and aggregation values the discriminant analysis allows a distinction of several subgroups especially with nephropathy and neuropathy (Table 6).Keywords
This publication has 6 references indexed in Scilit:
- Beta Thromboglobulin and Glycosylated Haemoglobin in Diabetes MellitusScandinavian Journal of Haematology, 2009
- Platelet aggregation after strict metabolic control using the artificial pancreasDiabetologia, 1982
- ABNORMALITIES OF ERYTHROCYTE DEFORMABILITY AND PLATELET AGGREGATION IN INSULIN-DEPENDENT DIABETICS CORRECTED BY INSULIN IN VIVO AND IN VITROThe Lancet, 1982
- Platelet function in diabetes mellitus in relationship to complications, glycosylated haemoglobin and serum lipoproteinsEuropean Journal of Clinical Investigation, 1981
- Hematologic alterations in diabetes mellitusAmerican Journal Of Medicine, 1981
- PLATELET FUNCTION IN DIABETES MELLITUSBritish Journal of Haematology, 1980